It is high time to ramp up our standards of financial education as we survey the wreckage of Woodford Equity Income fund and the public’s panicky response.
AJ Bell's largest shareholder sells more than a third of its stake, as Invesco's Mark Barnett banks big profit on investment he inherited from Neil Woodford.
Martin Currie Asia Unconstrained, the smallest and worst performing trust in its sector, is to be liquidated after board gives up efforts to gain investor interest.
UK’s largest listed life sciences fund takes another step away from its roots as Battle Against Cancer investment trust with chairman Jeremy Tigue announcing he will retire in December.
High-yielding leasing fund is one step closer to recovering $2.5 million (£2.2 million) it loaned to US solar cell manufacturer Suniva, now lifted from bankruptcy.
Research by Henderson International Income Trust reveals that a fifth of the £1 trillion paid in dividends globally last year came from unreliable companies.
Neil Woodford has effectively run his Patient Capital investment trust for free for four years but with his business shrinking he may have to get investors in the loss-making fund to pay more.
Woodford Patient Capital Trust is vulnerable to a takeover bid following today’s share price slide, according to a leading analyst at JP Morgan Cazenove.
Shareholders’ hopes of recovering much money from CatCo Reinsurance dwindle as its fund manager warns of need to raise reserves again in response to hurricane claims in US and Japan.
Perpetual Income & Growth has reported a third successive year of underperformance by fund manager Mark Barnett. The board says it grills Barnett but is it tough enough?